Article
Las Vegas - The FDA on Jan. 2 cleared Berlex Laboratories Inc. to market Finacea (azelaic acid 15 percent) gel for the treatment of rosacea.
Tirbanibulin Demonstrates Efficacy for Actinic Keratosis in Larger Field Treatment
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Disparities in Hidradenitis Suppurativa: A Closer Look at Skin of Color Populations
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Philip Mease, MD, Discusses Head-to-Head BE BOLD Clinical Trial
Benzene in Benzoyl Peroxide at Room Temperature: What Comes Next?